Health-care companies fell, but not by as much as the broad market, amid a generally strong round of earnings from drugmakers. AbbVie shares rose after the pharmaceutical company reported ...

Healthcare will always be around. But tech is just beginning. Why not mix them both together? The post This Healthcare Stock ...

Given their solid financials and healthy growth prospects, these three momentum stocks could continue their upward momentum.

Cyclerion Therapeutics CYCN stock moved upwards by 31.9% to $3.35 during Friday's pre-market session. The company's market cap stands at $9.0 million. LakeShore Biopharma LSB stock moved upwards by 21 ...

Sullivan said HHG's global stock picks for the year were Salesforce, a customer management system, which had revenue up 11 ...

Semiconductor stocks were once again at the forefront of media and investor attention this week during the stock market ...

Artificial intelligence continues to permeate throughout the economy, and one such example coming out of the healthcare sector is Tempus AI. Click to read.

AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...

With that being said, let’s move to the 10 best stocks for beginners with little money according to hedge funds.

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...